China Regenerative Medicine International Ltd. appointed Chen Chunguo as an executive director to the company's board.
Chen will serve for an initial term of two years.
Discover more about S&P Global’s offerings
China Regenerative Medicine appoints executive director
Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise
Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises
Essential IR Insights Newsletter - Summer July-August 2023
Insight Weekly: Climate law faces hurdles; US borrowing surges; banks revise uninsured deposits
China Regenerative Medicine International Ltd. appointed Chen Chunguo as an executive director to the company's board.
Chen will serve for an initial term of two years.